NCT01831440 - Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

December 31, 2014

Conditions

Depressive Disorder

Interventions

BEHAVIORAL

medicine combined CBT

medicine：Clinical routine antidepressant treatment CBT：During the treatment period，weekly for 8 weeks，and monthly for the maintenance phase.Therapists receive group supervision monthly.

DRUG

medicine

Participants receive only clinical routine antidepressant treatment,Which include fluoxetine (Prozac); sertraline (Zoloft); paroxetine (Paxil); citalopram (Celexa) ;escitalopram (Lexapro) and fluvoxamine (Luvox). It will be chosen according to special condition of every patient.

Trial Locations (1)

210029

RECRUITING

Nanjing Brain Hospital, Nanjing